TP53 and breast cancer: For example, paclitaxel mediates mitotic mutation and senescence in BC by downregulating FOXM1 [61], and upon treatment with epirubicin via an E2F-element on its promoter, p53 has been demonstrated to inhibit the transcription of FOXM1 in BC cells [62].